BioTime Inc, to change name to Lineage Cell Therapeutics Inc.
BioTime, Inc. a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, today announced it is launching a new corporate brand, including a change of its corporate name to Lineage Cell Therapeutics, Inc., effective August 12, 2019. In connection with the launch, the Company's NYSE American ticker symbol will change to "LCTX" and will be effective at the open of the market on August 12, 2019. The Company�s former ticker symbol �BTX� will remain effective through market close as of August 9, 2019.
The new website for Lineage Cell Therapeutics will be www.lineagecell.com. The Company�s new identity reflects its commitment to becoming an innovative, leading cell therapy company and highlights its extensive cell therapy platform.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.